Cancer of Prostate Clinical Trials

12 recruitingLast updated: June 18, 2026

There are 12 actively recruiting cancer of prostate clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Phase 1. Top locations include Bethesda, Maryland, United States, Toronto, Ontario, Canada, Hasselt, Belgium. Updated daily from ClinicalTrials.gov.


Cancer of Prostate Trials at a Glance

12 actively recruiting trials for cancer of prostate are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Bethesda, Toronto, and Hasselt. Lead sponsors running cancer of prostate studies include National Cancer Institute (NCI), Medtechtomarket Consulting Ltd, and Maastricht University Medical Center.

Browse cancer of prostate trials by phase

Treatments under study

About Cancer of Prostate Clinical Trials

Looking for clinical trials for Cancer of Prostate? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer of Prostate trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer of Prostate clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1Phase 2

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

Cancer of ProstateProstate Neoplasms
National Cancer Institute (NCI)86 enrolled1 locationNCT04633252
Recruiting

Collection of Blood From Patients With Prostate Cancer

Prostate CancerMetastatic Prostate CancerCancer of Prostate+2 more
National Cancer Institute (NCI)1,000 enrolled1 locationNCT00923221
Recruiting

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Prostate CancerProstatic CancerCancer of Prostate+2 more
National Cancer Institute (NCI)10,000 enrolled1 locationNCT03354416
Recruiting
Phase 2

A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Cancer of Prostate
National Cancer Institute (NCI)65 enrolled1 locationNCT05361798
Recruiting
Phase 2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Cancer of the BreastCancerAdjustment Disorder+8 more
Psyence Australia Pty Ltd87 enrolled3 locationsNCT07072728
Recruiting
Not Applicable

The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients

Cancer of Prostate
Maastricht University Medical Center45 enrolled1 locationNCT06406803
Recruiting
Phase 1

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Prostate CancerCancer of Prostate
Washington University School of Medicine24 enrolled1 locationNCT04887935
Recruiting
Not Applicable

Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer

Prostate CancerCancer of ProstateProstate Adenocarcinoma
Sunnybrook Health Sciences Centre144 enrolled1 locationNCT05600400
Recruiting

Investigation of Three Biomarkers for the Detection of Prostate Cancer

Cancer of Prostate
Medtechtomarket Consulting Ltd137 enrolled1 locationNCT06554587
Recruiting
Not Applicable

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Cancer of ProstateSedentary Behavior
University of Toronto120 enrolled1 locationNCT05214937
Recruiting

ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer

Cancer of ProstateCancer Head NeckCancer Cervix
University College, London990 enrolled6 locationsNCT05653063
Recruiting
Not Applicable

Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention

Cancer of Prostate
Fondazione del Piemonte per l'Oncologia120 enrolled2 locationsNCT06318559